CONMED Corporation Strategic Asset Allocation Index
CONMED Corporation strategic asset allocation index. CONMED Corporation (CNMD) has a Strategic Asset Allocation Index of 15.1% as of September 2023. Strategic assets (PP&E of $120.44 Million plus long-term investments of $-) total $120.44 Million, measured against net assets of $796.21 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See CNMD net asset quality score to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of CONMED Corporation (2000–2022)
Strategic asset allocation index of CONMED Corporation from 2000 to 2022. This chart shows how CONMED Corporation's Strategic Asset Allocation Index has evolved across 23 annual periods from 2000 to 2022. As of September 2023, the index stands at 15.1%, representing strategic assets of $120.44 Million against net assets of $796.21 Million USD. Check CONMED Corporation tangible equity quality to evaluate the tangible quality of the company's equity base.
CONMED Corporation Strategic Asset Allocation Index by Year (2000–2022)
CONMED Corporation strategic asset allocation index by year from 2000 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for CONMED Corporation from 2000 to 2022, covering 23 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see CNMD market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 15.5% | $115.61 Million | $115.61 Million | $- | $745.54 Million | ▲ +1.6 pp |
| 2021 | 13.9% | $108.86 Million | $108.86 Million | $- | $785.43 Million | ▼ -1.9 pp |
| 2020 | 15.7% | $111.41 Million | $111.41 Million | $- | $709.04 Million | ▼ -1.0 pp |
| 2019 | 16.7% | $118.88 Million | $118.88 Million | $- | $710.47 Million | ▼ -0.4 pp |
| 2018 | 17.1% | $113.25 Million | $113.25 Million | $- | $662.27 Million | ▼ -1.3 pp |
| 2017 | 18.4% | $116.23 Million | $116.23 Million | $- | $631.43 Million | ▼ -2.6 pp |
| 2016 | 21.0% | $122.03 Million | $122.03 Million | $- | $580.58 Million | ▼ -0.4 pp |
| 2015 | 21.4% | $125.45 Million | $125.45 Million | $- | $585.07 Million | ▼ -1.5 pp |
| 2014 | 23.0% | $133.43 Million | $133.43 Million | $- | $581.30 Million | ▲ +0.0 pp |
| 2013 | 22.9% | $138.99 Million | $138.99 Million | $- | $606.32 Million | ▲ +0.0 pp |
| 2012 | 22.9% | $139.04 Million | $139.04 Million | $- | $607.00 Million | ▼ -1.4 pp |
| 2011 | 24.3% | $139.19 Million | $139.19 Million | $- | $573.07 Million | ▲ +0.3 pp |
| 2010 | 24.0% | $140.90 Million | $140.90 Million | $- | $586.56 Million | ▼ -0.9 pp |
| 2009 | 24.9% | $143.50 Million | $143.50 Million | $- | $576.51 Million | ▼ -2.1 pp |
| 2008 | 27.0% | $143.74 Million | $143.74 Million | $- | $531.73 Million | ▲ +2.5 pp |
| 2007 | 24.5% | $123.68 Million | $123.68 Million | $- | $505.00 Million | ▼ -2.0 pp |
| 2006 | 26.5% | $116.48 Million | $116.48 Million | $- | $440.35 Million | ▲ +3.4 pp |
| 2005 | 23.0% | $104.22 Million | $104.22 Million | $- | $453.01 Million | ▲ +0.4 pp |
| 2004 | 22.6% | $101.47 Million | $101.47 Million | $- | $447.98 Million | ▲ +0.2 pp |
| 2003 | 22.5% | $97.38 Million | $97.38 Million | $- | $433.49 Million | ▼ -2.2 pp |
| 2002 | 24.7% | $95.61 Million | $95.61 Million | $- | $386.94 Million | ▼ -7.4 pp |
| 2001 | 32.1% | $91.03 Million | $91.03 Million | $- | $283.63 Million | ▲ +5.0 pp |
| 2000 | 27.1% | $62.45 Million | $62.45 Million | $- | $230.60 Million | — |